[PMID: 37940101]
The parents again filled out the ATEC, SAS, and PDD-BI, as well as the Parental Global Impressions questionnaire
It's calorie-efficient, leucine-rich (the amino acid most responsible for triggering muscle protein synthesis), and won't cause the heaviness or nausea that solid food can trigger on GLP-1 medications
The critical unanswered questions are whether MariTide's phase 2 results will replicate in phase 3, whether the GIP antagonism approach provides unique metabolic benefits (such as lean mass preservation) beyond weight loss, and whether the antibody-peptide conjugate format introduces any long-term immunogenicity concerns
The research data here comes from clinical trials, emerging endocrinology findings, and the practical experience of people who have navigated this exact combination
In West Virginia, the Public Employees Insurance Agency (PEIA) started a 1,000 person pilot program that covered GLP-1s to treat obesity beginning in 2019